HIV Citation List: December 23, 2011 - January 5, 2012

Pubmed citations

1. Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV Infection. Akanbi, M.O., K. Scarci, B. Taiwo, and R.L. Murphy, Expert Opinion on Pharmacotherapy, 2012. 13(1): p. 65-79; PMID[22149368].

[Pubmed]. HIV_1223-010512.

2. The Lectins Griffithsin, Cyanovirin-N and Scytovirin Inhibit HIV-1 Binding to the DC-SIGN Receptor and Transfer to CD4(+) Cells. Alexandre, K.B., E.S. Gray, H. Mufhandu, J.B. McMahon, E. Chakauya, B.R. O'Keefe, R. Chikwamba, and L. Morris, Virology, 2011. [Epub ahead of print]; PMID[22209231].

[Pubmed]. HIV_1223-010512.

3. CNS Effects of a CCR5 Inhibitor in HIV-infected Subjects: A Pharmacokinetic and Cerebral Metabolite Study. Garvey, L., M. Nelson, N. Latch, O.W. Erlwein, J.M. Allsop, A. Mitchell, S. Kaye, V. Watson, D. Back, S.D. Taylor-Robinson, and A. Winston, Journal of Antimicrobial Chemotherapy, 2012. 67(1): p. 206-212; PMID[21987241].
[Pubmed]. HIV_1223-010512.

4. Substrate Mimicry: HIV-1 Reverse Transcriptase Recognizes 6-Modified-3'-azido-2',3'-dideoxyguanosine-5'-triphosphates as Adenosine Analogs. Herman, B.D., R.F. Schinazi, H.W. Zhang, J.H. Nettles, R. Stanton, M. Detorio, A. Obikhod, U. Pradere, S.J. Coats, J.W. Mellors, and N. Sluis-Cremer, Nucleic Acids Research, 2012. 40(1): p. 381-390; PMID[21914723].
[Pubmed]. HIV_1223-010512.

5. Design and Synthesis of Novel Beta-diketo Derivatives as HIV-1 Integrase Inhibitors. Hu, L., S. Zhang, X. He, Z. Luo, X. Wang, W. Liu, and X. Qin, Bioorganic & Medicinal Chemistry, 2012. 20(1): p. 177-182; PMID[22154762].
[Pubmed]. HIV_1223-010512.

6. Mutational Patterns in the Frameshift-regulating Site of HIV-1 Selected by Protease Inhibitors. Knops, E., L. Brakier-Gingras, E. Schulter, H. Pfister, R. Kaiser, and J. Verheyen, Medical Microbiology and Immunology, 2011. [Epub ahead of print]; PMID[22200908].
[Pubmed]. HIV_1223-010512.

7. Elvitegravir: A Once-daily, Boosted, HIV-1 Integrase Inhibitor. Lampiris, H.W., Expert Review of Anti-Infective Therapy, 2012. 10(1): p. 13-20; PMID[22149610].
[Pubmed]. HIV_1223-010512.

8. Modification of HIV-1 Reverse Transcriptase and Integrase Activity by Gold(III) Complexes in Direct Biochemical Assays. Mphahlele, M., M. Papathanasopoulos, M.A. Cinellu, M. Coyanis, S. Mosebi, T. Traut, R. Modise, J. Coates, and R. Hewer, Bioorganic & Medicinal Chemistry, 2012. 20(1): p. 401-407; PMID[22104436].
[Pubmed]. HIV_1223-010512.

9. Induction of Strong anti-HIV Cellular Immunity by a Combination of Clostridium Perfringens Expressing HIV gag and Virus Like Particles. Pegu, P., R. Helmus, P. Gupta, P. Tarwater, L. Caruso, C. Shen, T. Ross, and Y. Chen, Current HIV Research, 2011. [Epub ahead of print]; PMID[22211658].
[Pubmed]. HIV_1223-010512.

10. Development of Anti-HIV Agents Based on Chemical Biology. Tamamura, H., Yakugaku Zasshi, 2012. 132(1): p. 69-78; PMID[22214582].
[Pubmed]. HIV_1223-010512.

ISI Web of Knowledge citations

11. 4'-C-Nucleoside Derivatives: Synthesis and Antiviral Properties. Alexandrova, L.A., Russian Journal of Bioorganic Chemistry, 2011. 37(6): p. 651-671; ISI[000297344600001].
[WOS]. HIV_1223-010512.

12. Electronic Structure and Spectral and Luminescent Properties of anti-HIV-active Aminophenols. Bazyl, O.K., V.Y. Artyukhov, and G.V. Mayer, Russian Physics Journal, 2011. 54(6): p. 619-626; ISI[000297545200001].
[WOS]. HIV_1223-010512.

13. The Identification of a Small Molecule Compound That Reduces HIV-1 Nef-Mediated Viral Infectivity Enhancement. Chutiwitoonchai, N., M. Hiyoshi, P. Mwimanzi, T. Ueno, A. Adachi, H. Ode, H. Sato, O.T. Fackler, S. Okada, and S. Suzu, Plos One, 2011. 6(11): e27696; ISI[000297555300043].
[WOS]. HIV_1223-010512.

14. Complex Drug Interactions of HIV Protease Inhibitors 2: In Vivo Induction and in Vitro to in Vivo Correlation of Induction of Cytochrome P450 1A2, 2B6, and 2C9 by Ritonavir or Nelfinavir. Kirby, B.J., A.C. Collier, E.D. Kharasch, V. Dixit, P. Desai, D. Whittington, K.E. Thummel, and J.D. Unadkat, Drug Metabolism and Disposition, 2011. 39(12): p. 2329-2337; ISI[000297317000020].
[WOS]. HIV_1223-010512.

15. Synthesis of New Acyclic Nucleoside Phosphonates (ANPs) Substituted on the 1 ' and/or 2 ' positions. Kundarapu, M., D. Marchand, S.G. Dumbre, and P. Herdewijn, Tetrahedron Letters, 2011. 52(51): p. 6896-6898; ISI[000297777600012].
[WOS]. HIV_1223-010512.

16. Modeling of Human Prokineticin Receptors: Interactions with Novel Small-molecule Binders and Potential Off-target Drugs. Levit, A., T. Yarnitzky, A. Wiener, R. Meidan, and M.Y. Niv, Plos One, 2011. 6(11); ISI[000297789900038].
[WOS]. HIV_1223-010512.

17. Toxicity of anti-HIV Drugs and the Use of Tempol as a Therapeutic Agent. Nguyen, P.G., Y.M. Liu, and M.C. Poirier, Environmental and Molecular Mutagenesis, 2011. 52: p. S74-S74; ISI[000297929800248].
[WOS]. HIV_1223-010512.

18. CpG Protects Human Monocytic Cells against HIV-V pr-Induced Apoptosis by Cellular Inhibitor of Apoptosis-2 through the Calcium-activated JNK Pathway in a TLR9-Independent Manner. Saxena, M., A. Busca, S. Pandey, M. Kryworuchko, and A. Kumar, Journal of Immunology, 2011. 187(11): p. 5865-5878; ISI[000297450000047].
[WOS]. HIV_1223-010512.

19. Plant as a Source of Natural Antiviral Agents. Sohail, M.N., F. Rasul, A. Karim, U. Kanwal, and I.H. Attitalla, Asian Journal of Animal and Veterinary Advances, 2011. 6(12): p. 1125-1152; ISI[000297537800002].
[WOS]. HIV_1223-010512.

20. An Efficient and Selective Route to Hybrid Trifluoromethyl-substituted Gamma-lactones or Fused Nitrogen Derivatives via Cascade Reactions. Tucaliuc, R., V.V. Cotea, C. Moldoveanu, G. Zbancioc, C. Deleanu, P.G. Jones, and Mangalagiu, II, Tetrahedron Letters, 2011. 52(48): p. 6439-6442; ISI[000297523700032].
[WOS]. HIV_1223-010512.

21. Human HERC5 Restricts an Early Stage of HIV-1 Assembly by a Mechanism Correlating with the ISGylation of gag. Woods, M.W., J.N. Kelly, C.J. Hattlmann, J.G.K. Tong, L.S. Xu, M.D. Coleman, G.R. Quest, J.R. Smiley, and S.D. Barr, Retrovirology, 2011. 8; ISI[000297755400001].
[WOS]. HIV_1223-010512.

22. Synthesis and in Vitro Enzymatic and Antiviral Evaluation of Phosphoramidate d4T Derivatives as Chain Terminators. Yang, S.Q., C. Pannecouque, E. Lescrinier, A. Girauta, and P. Herdewijn, Organic & Biomolecular Chemistry, 2012. 10(1): p. 146-153; ISI[000297589900024].
[WOS]. HIV_1223-010512.

Patent citations

23. Thioether Prodrug Compositions as anti-HIV and Anti-retroviral Agents. Appella, D., E. Appella, J.K. Inman, L.M. Miller Jenkins, R. Hayashi, and D. Wang. Patent. 2011-US39909 2011156674, 56pp.

[Patent]. HIV_1223-010512.

24. Pyrrolopyrazole Derivatives as HIV Replication Inhibitors and Their Preparation and Use for the Treatment of HIV Infection. Lepage, O., P.K. Bhardwaj, A.-M. Faucher, C. Grand-Maitre, J.-E. Lacoste, L. Lamorte, and J.-F. Mercier. Patent. 2011-CA50308 2011143772, 78pp.

[Patent]. HIV_1223-010512.

25. Plant-derived Compositions Comprising an Extract of Rubia cordifolia for Treatment of HIV Infection. Nair, M.P.N., Z.M. Saiyed, and N.H. Gandhi. Patent. 2011-US35922 2011143218, 15pp.

[Patent]. HIV_1223-010512.

26. Novel CXCR4 Inhibitors as anti-HIV Agents. Puig de la Bellacasa Cazorla, R., J.I. Borrell Bilbao, J. Teixido Closa, and J. Este Araque. Patent. 2011-ES70407 2011154580, 38pp.

[Patent]. HIV_1223-010512.

27. Preparation of C28 Amides of Modified C3 Betulinic acid Derivatives as HIV Maturation Inhibitors. Regueiro-Ren, A., Z. Liu, J. Swidorski, N.A. Meanwell, S.-Y. Sit, J. Chen, Y. Chen, and N. Sin. Patent. 2011-US38884

2011153319, 338pp.

[Patent]. HIV_1223-010512.

28. Preparation of Modified C3 Betulinic acid Derivatives as HIV Maturation Inhibitors. Regueiro-Ren, A., J. Swidorski, Z. Liu, N.A. Meanwell, S.-Y. Sit, and J. Chen. Patent. 2011-US38879 2011153315, 157pp.

[Patent]. HIV_1223-010512.

29. Anti-HIV Activity of the Opioid Antagonist Naloxone. Ugen, K.E., S. Specter, S.B. Nyland, and C. Cao. Patent. 2004-902471 8067430, 10pp.

[Patent]. HIV_1223-010512.